MannKind Corp MNKD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 3:13 PM EDT
4.20quote price arrow up+0.52 (+13.99%)
Volume
22,154,000
52 week range
2.49 - 5.53
Loading...
  • Open3.73
  • Day High4.77
  • Day Low3.57
  • Prev Close3.68
  • 52 Week High5.53
  • 52 Week High Date06/30/21
  • 52 Week Low2.49
  • 52 Week Low Date02/28/22

Key Stats

  • Market Cap1.06B
  • Shares Out252.57M
  • 10 Day Average Volume5.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.83
  • YTD % Change-3.89

KEY STATS

  • Open3.73
  • Day High4.77
  • Day Low3.57
  • Prev Close3.68
  • 52 Week High5.53
  • 52 Week High Date06/30/21
  • 52 Week Low2.49
  • 52 Week Low Date02/28/22
  • Market Cap1.06B
  • Shares Out252.57M
  • 10 Day Average Volume5.61M
  • Dividend-
  • Dividend Yield-
  • Beta1.83
  • YTD % Change-3.89

RATIOS/PROFITABILITY

  • EPS (TTM)-0.38
  • P/E (TTM)-11.18
  • Fwd P/E (NTM)-12.99
  • EBITDA (TTM)-61.47M
  • ROE (TTM)-
  • Revenue (TTM)70.00M
  • Gross Margin (TTM)39.65%
  • Net Margin (TTM)-134.30%
  • Debt To Equity (MRQ)-165.71%

EVENTS

  • Earnings Date08/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On MannKind Corp

There is no recent news for this security.

Profile

MORE
MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler....
James Shannon M.D.
Independent Chairman of the Board
Michael Castagna Pharm.D.
Chief Executive Officer, Director
Steven Binder CPA
Chief Financial Officer
Joseph Kocinsky
Chief Technology Officer
David Thomson J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Address
1 CASPER STREET
Danbury, CT
06810
United States

Top Peers

SYMBOLLASTCHG%CHG
RVNC
Revance Therapeutics Inc
13.09-0.67-4.87%
ENTA
Enanta Pharmaceuticals Inc
41.85-0.02-0.05%
KDNY
Chinook Therapeutics Inc
14.94-0.07-0.47%
RXRX
Recursion Pharmaceuticals Inc
5.84+0.43+7.95%
NGM
NGM Biopharmaceuticals Inc
13.83-0.02-0.14%